Activity of tribendimidine and praziquantel combination therapy against the liver fluke <em>Opisthorchis viverrini</em> <em>in vitro</em> and <em>in... (Publications)
Opisthorchiasis, caused by the liver fluke Opisthorchis viverrini, a food-borne trematode, is an important public health problem; however, only a single drug, praziquantel is available. We investigate
Chlorination disinfection by-products and risk of congenital anomalies in England and Wales (Publications)
BACKGROUND: Increased risk of various congenital anomalies has been reported to be associated with trihalomethane (THM) exposure in the water supply. OBJECTIVES: We conducted a registry-based study to
Retail sector distribution chains for malaria treatment in the developing world: a review of the literature (Publications)
BACKGROUND: In many low-income countries, the retail sector plays an important role in the treatment of malaria and is increasingly being considered as a channel for improving medicine availability. R
Tetanus immunisation in geriatric patients with accidental wounds: how much is needed? (Publications)
OBJECTIVE: In the industrialised world, the elderly carry the highest risk for tetanus. This prospective serological study was performed to evaluate the reliability of tetanus immunisation histories a
Comparative analysis of two methods for measuring sales volumes during malaria medicine outlet surveys (Publications)
BACKGROUND: There is increased interest in using commercial providers for improving access to quality malaria treatment. Understanding their current role is an essential first step, notably in terms o
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa (Publications)
BACKGROUND: RTS,S/AS01 is a safe and moderately efficacious vaccine considered for implementation in endemic Africa. Model predictions of impact and cost-effectiveness of this new intervention could a
Forscher im Kampf gegen Malaria [TV Broadcast] (Publications)
Malaria gehört zu den drei schlimmsten Infektionskrankheiten der Welt, neben Tuberkulose und HIV. Basler Wissenschaftler haben eine ganz neue Substanz entdeckt, die den hartnäckigen Erreger töten kann